GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » Cash Flow from Discontinued Operations

Sunho Biologics (HKSE:02898) Cash Flow from Discontinued Operations : HK$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Sunho Biologics Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Sunho Biologics's cash flow from discontinued operations for the six months ended in Jun. 2024 was HK$0.00 Mil. It means Sunho Biologics received HK$0.00 Mil from the sale of part of business quarterly. Sunho Biologics's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.00 Mil.

Sunho Biologics Cash Flow from Discontinued Operations Historical Data

The historical data trend for Sunho Biologics's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunho Biologics Cash Flow from Discontinued Operations Chart

Sunho Biologics Annual Data
Trend Dec22 Dec23
Cash Flow from Discontinued Operations
- -

Sunho Biologics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Cash Flow from Discontinued Operations - - - -

Sunho Biologics Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunho Biologics Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Sunho Biologics's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunho Biologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunho Biologics Inc (HKSE:02898) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 198 Peninsula Middle Road, Dipu Street, Room 302, Building 3, Anji County, Zhejiang Province, Huzhou, CHN
Website
http://www.sunho-bio.com.cn
Sunho Biologics Inc is a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of biologics for the treatment of cancers and autoimmune diseases. It has three Core Products, IAH0968, IAP0971, and IAE0972, all of which are developed in-house. IAH0968 is an antibody-dependent cell-mediated cytotoxicity (ADCC) enhanced monoclonal antibody (mAb), and the company has initiated Phase II clinical trials for biliary tract carcinoma (BTC) and colorectal cancer (CRC). IAP0971 and IAE0972 are both immunocytokines and It has completed Phase I clinical trials for advanced solid tumors including non-small cell lung cancer (NSCLC) and CRC.
Executives
Sunho Fortune Investments Limited 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Zhang Feng 2201 Interest of corporation controlled by you
Sunho Wisdom Investments Limited 2101 Beneficial owner

Sunho Biologics Headlines

No Headlines